About iSirona
iSirona is a company based in El Segundo (United States) founded in 2007 by Joe Kiani was acquired by NantHealth in January 2013. iSirona has raised $1.5 million across 2 funding rounds from investors including NantHealth and Abraxis BioScience. The company has 1,317 employees as of December 31, 2021. iSirona offers products and services including Iris Gateway, Pulse Oximetry, and Root. iSirona operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
- Headquarter El Segundo, United States
- Employees 1317 as on 31 Dec, 2021
- Founders Joe Kiani
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Oct 27, 2009
-
Investors
NantHealth
& 1 more
-
Employee Count
1317
as on Dec 31, 2021
-
Acquired by
NantHealth
(Jan 01, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of iSirona
iSirona offers a comprehensive portfolio of products and services, including Iris Gateway, Pulse Oximetry, and Root.
Facilitates data transfer from medical devices to electronic records
Measures blood oxygen levels for patient vital signs
Integrates various monitoring technologies for hospital use
Funding Insights of iSirona
iSirona has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iSirona
iSirona has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NantHealth and Abraxis BioScience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Protein-based nanoparticle chemotherapeutics for cancer are developed.
|
Locked | Locked | Locked | |
|
Bioinformatics platforms are provided for cancer treatment identification.
|
Locked | Locked | Locked |
Investor details for iSirona
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iSirona
Investment portfolio details for iSirona
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iSirona
Detailed financials for iSirona
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Isirona Comparisons
Peer comparison for iSirona
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iSirona
iSirona operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Endotronix and Athelas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
Detailed competitors of iSirona
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Isirona
Complete news archive for iSirona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iSirona
iSirona was founded in 2007 and raised its 1st funding round 1 year after it was founded.
iSirona is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
Joe Kiani is the current CEO of iSirona. They have also founded this company.
iSirona is a funded company, having raised a total of $1.5M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at iSirona is 1,317.
Digital patient monitoring tool for providers. The companys innovative noninvasive patient monitoring technologies, hospital automation systems, home monitoring devices, ventilation solutions, and consumer items are all developed and produced by a medical technology business. It provides home health management tools including continuous thermometers that are of hospital-grade quality. Additionally, the business offers Masimo SafetyNet, a monitoring system for young patients.
iSirona's top competitors include Tyto Care, Endotronix and Athelas.
iSirona offers Iris Gateway, Pulse Oximetry, and Root.
iSirona has 2 investors. Key investors include NantHealth, and Abraxis BioScience.